230 related articles for article (PubMed ID: 8388713)
1. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.
Simon DI; Stamler JS; Jaraki O; Keaney JF; Osborne JA; Francis SA; Singel DJ; Loscalzo J
Arterioscler Thromb; 1993 Jun; 13(6):791-9. PubMed ID: 8388713
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
Tsikas D; Ikic M; Tewes KS; Raida M; Frölich JC
FEBS Lett; 1999 Jan; 442(2-3):162-6. PubMed ID: 9928994
[TBL] [Abstract][Full Text] [Related]
3. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Keaney JF; Simon DI; Stamler JS; Jaraki O; Scharfstein J; Vita JA; Loscalzo J
J Clin Invest; 1993 Apr; 91(4):1582-9. PubMed ID: 8473501
[TBL] [Abstract][Full Text] [Related]
4. Copper chelation-induced reduction of the biological activity of S-nitrosothiols.
Gordge MP; Meyer DJ; Hothersall J; Neild GH; Payne NN; Noronha-Dutra A
Br J Pharmacol; 1995 Mar; 114(5):1083-9. PubMed ID: 7780643
[TBL] [Abstract][Full Text] [Related]
5. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
Freedman JE; Frei B; Welch GN; Loscalzo J
J Clin Invest; 1995 Jul; 96(1):394-400. PubMed ID: 7615810
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.
Stamler JS; Simon DI; Jaraki O; Osborne JA; Francis S; Mullins M; Singel D; Loscalzo J
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8087-91. PubMed ID: 1325644
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
10. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
Stamler JS; Osborne JA; Jaraki O; Rabbani LE; Mullins M; Singel D; Loscalzo J
J Clin Invest; 1993 Jan; 91(1):308-18. PubMed ID: 8380812
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
12. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
[TBL] [Abstract][Full Text] [Related]
13. S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat.
Tsikas D; Sandmann J; Luessen P; Savva A; Rossa S; Stichtenoth DO; Frölich JC
Biochim Biophys Acta; 2001 Apr; 1546(2):422-34. PubMed ID: 11295447
[TBL] [Abstract][Full Text] [Related]
14. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione.
Askew SC; Butler AR; Flitney FW; Kemp GD; Megson IL
Bioorg Med Chem; 1995 Jan; 3(1):1-9. PubMed ID: 8612040
[TBL] [Abstract][Full Text] [Related]
15. Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet function.
Inbal A; Gurevitz O; Tamarin I; Eskaraev R; Chetrit A; Novicov I; Feldman M; Varon D; Eldar M; Loscalzo J
Blood; 1999 Sep; 94(5):1693-700. PubMed ID: 10477694
[TBL] [Abstract][Full Text] [Related]
16. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Neild GH; Dutra AA
Br J Pharmacol; 1996 Oct; 119(3):533-8. PubMed ID: 8894174
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
18. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.
Radomski MW; Rees DD; Dutra A; Moncada S
Br J Pharmacol; 1992 Nov; 107(3):745-9. PubMed ID: 1335336
[TBL] [Abstract][Full Text] [Related]
19. Extra-platelet low-molecular-mass thiols mediate the inhibitory action of S-nitrosoalbumin on human platelet aggregation via S-transnitrosylation of the platelet surface.
Tsikas D
Amino Acids; 2021 Apr; 53(4):563-573. PubMed ID: 33586042
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides.
Xian M; Chen X; Liu Z; Wang K; Wang PG
J Biol Chem; 2000 Jul; 275(27):20467-73. PubMed ID: 10779505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
